For Quick Alerts
For Daily Alerts
BioNTech, Pfizer ask Europe to OK vaccine for emergency use
Berlin, Dec 01: German pharmaceutical company BioNTech and its US partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency.
The two companies said on Tuesday that the submission, which occurred Monday, completes the rolling review process they initiated with the agency on October 6.
Never spoke about inoculating entire country with COVID-19 vaccine: Govt
The move comes a day after rival Moderna said it was asking US and European regulators to allow emergency use of its COVID-19 vaccine.
Recommended Video
Farmer
Protest:
Farmers' meet
with
centre
ends,
no
decision
yet|Oneindia
News
BioNTech said that if the vaccine, currently named BNT162b2, is approved, its use in Europe could begin before the end of 2020.